The Common G-866a Polymorphism of the Ucp2 Gene and Survival in Diabetic Patients following Myocardial Infarction

[1]  T. Horvath,et al.  UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals , 2009, Nature.

[2]  M. Marre,et al.  The Common −866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men , 2008, Diabetes.

[3]  F. Graziani,et al.  Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes , 2008, Mediators of inflammation.

[4]  C. Boni,et al.  Gender-related differences in oxidative stress levels among elderly patients with coronary artery disease. , 2008, Fertility and sterility.

[5]  A. Sureda,et al.  Lymphocyte antioxidant response and H2O2 production after a swimming session: Gender differences , 2008, Free radical research.

[6]  S. Humphries,et al.  Interaction between the uncoupling protein 2 -866G>A gene variant and cigarette smoking to increase oxidative stress in subjects with diabetes. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[7]  A. Martí,et al.  Association between obesity and insulin resistance with UCP2-UCP3 gene variants in Spanish children and adolescents. , 2007, Molecular genetics and metabolism.

[8]  V. Cameron,et al.  Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. , 2007, Journal of the American College of Cardiology.

[9]  E. Ropelle,et al.  The FASEB Journal • Research Communication Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion , 2022 .

[10]  V. Cameron,et al.  Association of the aldosterone synthase gene C-344T polymorphism with risk factors and survival in a post-myocardial infarction cohort , 2007, Journal of Human Hypertension.

[11]  S. Humphries,et al.  Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. , 2007, Clinical chemistry.

[12]  V. Cameron,et al.  Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. , 2006, American heart journal.

[13]  V. Cameron,et al.  Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure , 2006, Hypertension.

[14]  P. Sullivan,et al.  The emerging functions of UCP2 in health, disease, and therapeutics. , 2006, Antioxidants & redox signaling.

[15]  M. Brand,et al.  Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. , 2005, Cell metabolism.

[16]  O. Vuolteenaho,et al.  Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion. , 2004, American journal of physiology. Heart and circulatory physiology.

[17]  S. Humphries,et al.  Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. , 2004, European heart journal.

[18]  T. Ogihara,et al.  A common polymorphism of uncoupling protein 2 gene is associated with hypertension , 2004, Journal of hypertension.

[19]  C. Frampton,et al.  B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction , 2003, Circulation.

[20]  P. Marchetti,et al.  A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. , 2003, Diabetes.

[21]  V. Cameron,et al.  Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. , 2003, Journal of the American College of Cardiology.

[22]  J. Blanc,et al.  Protective Role of Uncoupling Protein 2 in Atherosclerosis , 2003, Circulation.

[23]  Kazuo Haze,et al.  Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes , 2002, Circulation.

[24]  H. Esterbauer,et al.  A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. , 2002, Diabetes.

[25]  A. Nègre-Salvayre,et al.  Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[26]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[27]  P. Ježek,et al.  Mechanism of uncoupling protein action. , 2001, Biochemical Society transactions.

[28]  B. Paulweber,et al.  A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans , 2001, Nature Genetics.

[29]  B. Miroux,et al.  Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production , 2000, Nature Genetics.

[30]  J G Turner,et al.  Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction , 1999, Heart.

[31]  Christophe Fleury,et al.  Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia , 1997, Nature Genetics.

[32]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.